(Q37336610)

19 August 2017

1 reference

title

Inhibitor of apoptosis proteins in hematological malignancies (English)

1 reference

19 August 2017

0 references

S Fulda

1

0 references

publication date

27 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

23

1 reference

19 August 2017

467-476

1 reference

19 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2008.329

19 August 2017

0 references

cites work

The biochemistry of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Apoptosis-based therapies for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Apoptosis in leukemia: from molecular pathways to targeted therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Proliferation, cell cycle and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

TRAIL signalling: decisions between life and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The CD95(APO-1/Fas) DISC and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Mitochondrial membrane permeabilization in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The apoptosome: signalling platform of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The inhibitors of apoptosis (IAPs) as cancer targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

IAPs, RINGs and ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

CARD proteins as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Structural basis of caspase-7 inhibition by XIAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Structural basis for the inhibition of caspase-3 by XIAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Mechanism of XIAP-mediated inhibition of caspase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

XIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 Dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Ubiquitin-mediated regulation of TNFR1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Human cancer cells harbor T-stumps, a distinct class of extremely short telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Livin, a novel inhibitor of apoptosis protein family member

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Subcellular localization determines the delicate balance between the anti- and pro-apoptotic activity of Livin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

A p34(cdc2) survival checkpoint in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

An IAP-IAP complex inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Mammalian mitochondrial IAP binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Structural basis of IAP recognition by Smac/DIABLO

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Requirement of Both the Second and Third BIR Domains for the Relief of X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Caspase Inhibition by Smac

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The mitochondrial serine protease HtrA2/Omi: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Identification of XAF1 as an antagonist of XIAP anti-Caspase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Expression of C-IAP1, C-IAP2 and SURVIVIN discriminates different types of lymphoid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Apoptotic effect of fludarabine is independent of expression of IAPs in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Expression of IAP-family proteins in adult acute mixed lineage leukemia (AMLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Analysis of human transcriptomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Survivin, a cancer target with an emerging role in normal adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

XAF1 expression is significantly reduced in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Structure-based design, synthesis and biochemical testing of novel and potent Smac peptido-mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Role of Smac in human leukaemic cell apoptosis and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Cellular, biochemical, and genetic analysis of mechanism of small molecule IAP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Chemosensitization effects of XIAP downregulation in K562 leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

xIAP induces cell-cycle arrest and activates nuclear factor-kappaB : new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

Significant impact of survivin on myeloma cell growth.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

XIAP targeting sensitizes Hodgkin lymphoma cells for cytolytic T-cell attack

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.329

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.329

1 reference

19 August 2017

1 reference

PubMed ID

19039324